Arkolith/Insider Trading/TSHA/Form 4

Session R.A. II

10% OwnerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Jun 22, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$307K
Net Open-Market Flow
-$307K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2023Sell(S)139K$0.70$97K9.0M
Jun 20, 2023Sell(S)296K$0.71$210K9.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-016232) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML